The efficacy of placebo for the treatment of cancer-related fatigue: a systematic review and meta-analysis
Cancer-related fatigue (CRF) is a common symptom among patients with cancer. The efficacy of placebo, however, was never the main objective of any meta-analysis. Predicting the efficacy of placebo may facilitate researchers in designing future clinical trials for the treatment of CRF.
We performed a systematic review searching for prospective clinical trials comparing any treatment versus placebo for the treatment of CRF. We included studies that enrolled patients with any primary site of neoplasia and any stage of cancer. We excluded all studies that assessed fatigue related to any treatment. The primary endpoint of this study is the mean effect of placebo on fatigue according to the Functional Assessment of Chronic Illness (FACIT-F) and Brief Fatigue Inventory (BFI) scales. The secondary endpoint was the proportion of patients who reported improvement in fatigue (response rate).
We found 520 studies, and 29 studies with 3758 participants were included in the meta-analysis. Placebo had a mean effect of + 4.88 (95%CI + 2.45 to + 7.29) using the FACIT-F scale, although it was statistically worse than the interventions studied (p = 0.005). Using the BFI scale, placebo had an average effect of + 0.64 (95%CI + 0.02 to + 1.30), although it was also worse than the other interventions studied (p = 0.002). In terms of the response rate, 29% (95%CI 25–32%) of patients taking a placebo reported a significant improvement in CRF compared with 36% of patients treated with other interventions (p = 0.030).
Placebo treatments had a significant effect on CRF, and predicting these effects may help design future studies for CRF.
KeywordsFatigue Cancer Placebo effect Palliative care
The authors thank Dr. Ana Luiza Cabrera for her kind advice in developing the search strategy.
This study was funded by Centro de Estudos e Pesquisa de Hematologia e Oncologia. Faculdade de Medicina do ABC, Santo André, Brazil.
Compliance with ethical standards
Conflict of interest
PNAJ has received speaker’s honoraria from Merck Co. All other authors have no conflicts to disclose.
- 2.Mock V, Atkinson A, Barsevick A et al (2000) NCCN practice guidelines for cancer-related fatigue. Oncology (Williston Park) 14:151–161Google Scholar
- 5.Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59:565–590. https://doi.org/10.1146/annurev.psych.59.113006.095941 CrossRefGoogle Scholar
- 10.Higgins J, Green S (2011) Cochrane handbook for systematic reviews of interventions. The Cochrane CollaborationGoogle Scholar
- 11.Furlan AD, Malmivaara A, Chou R, Maher CG, Deyo RA, Schoene M, Bronfort G, van Tulder M, Editorial Board of the Cochrane Back, Neck Group. (2015) 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group. Spine (Phila Pa 1976) 40:1660–1673. https://doi.org/10.1097/BRS.0000000000001061
- 12.Wilson DB Practical meta-analysis effect size calculator [Online calculator]. https://www.campbellcollaboration.org/research-resources/research-for-resources/effect-size-calculator.html. Accessed 4 Jul 2019
- 16.Balk J, Day R, Rosenzweig M, Beriwal S (2009) Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol 7:4–11Google Scholar
- 17.da Costa Miranda V, Trufelli DC, Santos J, Campos MP, Nobuo M, da Costa Miranda M, Schlinder F, Riechelmann R, del Giglio A (2009) Effectiveness of guaraná (Paullinia cupana ) for postradiation fatigue and depression: results of a pilot double-blind randomized study. J Altern Complement Med 15:431–433. https://doi.org/10.1089/acm.2008.0324 CrossRefGoogle Scholar
- 19.Richard PO, Fleshner NE, Bhatt JR, Hersey KM, Chahin R, Alibhai SMH (2015) Phase II, randomised, double-blind, placebo-controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH-agonist therapy. BJU Int 116:744–752. https://doi.org/10.1111/bju.12755 CrossRefGoogle Scholar
- 22.Spathis A, Fife K, Blackhall F, Dutton S, Bahadori R, Wharton R, O’Brien M, Stone P, Benepal T, Bates N, Wee B (2014) Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial. J Clin Oncol 32:1882–1888. https://doi.org/10.1200/JCO.2013.54.4346 CrossRefGoogle Scholar
- 23.Stockler MR, O’Connell R, Nowak AK et al (2007) Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial. Lancet Oncol 8:603–612. https://doi.org/10.1016/S1470-2045(07)70148-1 CrossRefGoogle Scholar
- 24.Chen HW, Lin IH, Chen YJ, et al (2012) A novel infusible botanically-derived drug, PG2, for cancer-related fatigue: a phase II double-blind, randomized placebo-controlled study. Clin Investig Med 35:1–11Google Scholar
- 25.Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E (2013) Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31:3076–3082. https://doi.org/10.1200/JCO.2012.44.4661 CrossRefGoogle Scholar
- 26.Yennurajalingam S, Tannir NM, Williams JL, Lu Z, Hess KR, Frisbee-Hume S, House HL, Lim ZD, Lim KH, Lopez G, Reddy A, Azhar A, Wong A, Patel SM, Kuban DA, Kaseb AO, Cohen L, Bruera E (2017) A double-blind, randomized, placebo-controlled trial of panax ginseng for cancer-related fatigue in patients with advanced cancer. J Natl Compr Cancer Netw 15:1111–1120. https://doi.org/10.6004/jnccn.2017.0149 CrossRefGoogle Scholar
- 27.Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL (2010) Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer 18:179–187. https://doi.org/10.1007/s00520-009-0642-2 CrossRefGoogle Scholar
- 28.Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL (2013) Wisconsin ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 105:1230–1238. https://doi.org/10.1093/jnci/djt181 CrossRefGoogle Scholar
- 29.Berenson JR, Yellin O, Shamasunder HK, Chen CS, Charu V, Woliver TB, Sanani S, Schlutz M, Nassir Y, Swift RA, Andreu-Vieyra C, Vescio R (2015) A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma. Support Care Cancer 23:1503–1512. https://doi.org/10.1007/s00520-014-2486-7 CrossRefGoogle Scholar
- 32.Bruera E, Yennurajalingam S, Palmer JL, Perez-Cruz PE, Frisbee-Hume S, Allo JA, Williams JL, Cohen MZ (2013) Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial. J Clin Oncol 31:2421–2427. https://doi.org/10.1200/JCO.2012.45.3696 CrossRefGoogle Scholar
- 35.Cruciani RA, Zhang JJ, Manola J, Cella D, Ansari B, Fisch MJ (2012) L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial. J Clin Oncol 30:3864–3869. https://doi.org/10.1200/JCO.2011.40.2180 CrossRefGoogle Scholar
- 37.Mar Fan HG, Clemons M, Xu W, Chemerynsky I, Breunis H, Braganza S, Tannock IF (2008) A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Support Care Cancer 16:577–583. https://doi.org/10.1007/s00520-007-0341-9 CrossRefGoogle Scholar
- 38.Heckler CE, Garland SN, Peoples AR, Perlis ML, Shayne M, Morrow GR, Kamen C, Hoefler J, Roscoe JA (2016) Cognitive behavioral therapy for insomnia, but not armodafinil, improves fatigue in cancer survivors with insomnia: a randomized placebo-controlled trial. Support Care Cancer 24:2059–2066. https://doi.org/10.1007/s00520-015-2996-y CrossRefGoogle Scholar
- 39.Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, Peppone L, Hemstad A, Esparaz BT, Hopkins JO (2010) A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy. Cancer 116:3513–3520. https://doi.org/10.1002/cncr.25083 CrossRefGoogle Scholar
- 40.Lesser GJ, Case D, Stark N, et al (2014) Fatigue in newly diagnosed patients with breast cancer. J Support Oncol Author manuscript; available PMC 2014 March 01 2013 March ; 11(1) 31–42 101016/j.suponc201203003 11:31–42. https://doi.org/10.1016/j.suponc.2012.03.003.A